Teva Pharmaceutical Industries (TEVA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding [Yahoo! Finance]
3 Catalysts That Could Send Teva Stock to $40 and Beyond [Globe and Mail, The (Toronto, Canada)]
How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars [Yahoo! Finance]
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners